Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 546 results for "fda centre for drug evaluation and re..."

US FDA grants priority review status to Pfizer's Palbociclib NDA

Pfizer, announced the New Drug Application (NDA) for palbociclib has been accepted for filing and granted Priority Review by the United States Food and Drug Administration (US FDA). This NDA requests FDA approval of palbociclib, in combination with ... PharmaBiz, 2 weeks ago

5 images for fda centre for drug evaluation and research

U.S. Food and Drug Administration, 3 days ago
Grist Magazine, 4 weeks ago
Genetic Engineering News, 2 weeks ago
Grist Magazine, 4 weeks ago
Grist Magazine, 4 weeks ago
The Freepress Journal

US approves first vaccine against dangerous meningitis strain

Washington: The US Food and Drug Administration (FDA) has approved the first vaccine against meningitis B following outbreaks in several college campuses over the past year. The vaccine Trumenba, to be manufactured by Pfizer, is approved for ...
 ZeeNews.com1 day ago US FDA approves AbbVie's Humira to treat patients with moderately to severely active Crohn's disease  PharmaBiz1 month ago

Appraisal of evidence base for introduction of new implants in hip and knee replacement: a systematic review of five widely used device technologies

Marc J Nieuwenhuijse , research fellow ICOR and FDA 1 2 3 , R G H H Nelissen , professor 2 , J W Schoones , information specialist 4 , A Sedrakyan , associate professor 1 3 1 Patient Centered Comparative Effectiveness Program and US Food and Drug ...
 British Medical Journal1 month ago

Minomic Launches US Pilot Study of MiStat(TM) Novel Prostate Cancer Screening Technology

Key evaluation to inform the US Food and Drug Administration regulatory submission Prominent urology trials consortium The CUSP Group LLC to oversee study of the MiStat technology Initial pilot investigation will be followed by larger pivotal ...
 Asian Hospital & Healthcare Management1 month ago

Nanoparticles in Biotechnology, Drug Development and Drug Delivery

NEW YORK, Sept. 4, 2014 /PRNewswire/ -- announces that a new market research report is available in its catalogue: This BCC Research report provides detailed product analyses within health and wellness subsegments to overall ...
 Reliance Trust1 month ago

CNIO researchers associate 2 oncogenes with the aggressiveness and incidence of leukemia in mice

By a News Reporter-Staff News Editor at Clinical Trials Week Proteins regulating cell division determine tumour growth. Ongoing clinical trials are currently studying inhibitors for two of these proteins, Cdk4 and Cdk6, targeting several types of ...
 Pharmacy Choice4 days ago CNIO Researchers Link 2 Oncogenes With the Agressiveness and Incidence of Leukaemia in Mice  MedIndia3 weeks ago Study: 2 Oncogenes Linked With the Aggressiveness and Incidence of Leukemia in Mice  MedIndia2 weeks ago Two oncogenes linked to agressiveness and incidence of leukemia in mice  Science Daily3 weeks ago

Matter over Mind: Do Behavioural Drugs Make Us Better?

Most psychiatric patients surrender to drug therapy - believing, in the end, that they have little choice - but they nearly always act as resistance fighters along the way. They fail to comply fully with doctors' orders or they experiment with ...
 ABC Online3 weeks ago

National Institutes of Health to fund next phase of Tissue Chip for Drug Screening programme

The National Institutes of Health (NIH) will award funds to support the next phase of its Tissue Chip for Drug Screening programme to improve ways of predicting drug safety and effectiveness. Researchers will collaborate over three years to refine ...
 PharmaBiz1 month ago

Our products meet the statutory and regulatory requirements of the EU

More than five decades old, Mumbai-based manufacturer of laboratory/ magnetic stirrers and centrifuges, and blood bank refrigerators/freezers, Remi Elektrotechnik has crossed several milestones since inception. With a small manufacturing unit in ...
 Express Pharma1 month ago

Amgen presents data from phase 3 SHIFT study evaluating ivabradine in patients with chronic HF at HFSA

Amgen announced data from the phase 3 SHIFT (Systolic Heart failure treatment with the If inhibitor ivabradine Trial) study evaluating ivabradine in patients with chronic heart failure (HF) were presented at the 18th Annual Scientific Meeting of the ...
 PharmaBiz1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less